Your current location:HomeNewsCompany news
Zhejiang Huajun Pharmaceutical Co., Ltd. went to " The First China Peptide Industry Forum and the In
2019-08-19

Date:

Number of visits:

0

        On August 15-17, Gao Liugen, the vice-president of China Biochemical Pharmaceutical Industry Association (“CBPIA”), together with Zhou Zhengbing, the general manager of Zhejiang Huajun Pharmaceutical Industry Co., Ltd., and Dr. Zheng Wei, the chief scientist, were invited to attend 'the First China Peptide Industry Forum and the Inaugural Meeting of Peptide Society of China Biochemical Pharmaceutical Industry Association' held in Hefei, Anhui Province.


Zhejiang Huajun Pharmaceutical Co., Ltd. went to


     The meeting was hosted by CBPIA and organized by the Peptide Society of CBPIA. Hu Wenyan, the executive vice-president and secretary-general of CBPIA, presided over the opening ceremony. The forum invited representatives of government departments such as Bian Zhenjia, the former deputy director of the State Food and Drug Administration, Huang Xiaolong, the minister of second department of chemical pharmacy NMPA CDE. Researchers from universities and research institutes such as Zhao Yufen, academician of the Chinese Academy of Sciences, Li Yanmei, professor of the Chemistry Department of Tsinghua University, and representatives from peptide industry as speakers and participants.

    The main venue and three sub-venues were set up to discuss the situation and policy of peptide industry, the research and innovation, production and quality of peptide drugs, and the hot issues related to the listing of science and technology innovation board of biopharmaceutical enterprises.


Zhejiang Huajun Pharmaceutical Co., Ltd. went to

    

The Peptide Society of CBPIA aims to establish an integrated platform of producing-study-research, including basic research on peptide, drug research and development, industrial production and clinical application, to build a bridge for cooperation and mutual assistance between researchers and enterprises, and to promote the innovation and development of Chinese peptide with colleagues in this industry.


Zhejiang Huajun Pharmaceutical Co., Ltd. went to


Huajun Pharmaceutical Co., Ltd. positioned to developed and produced “amino acid synthetic peptide APIs and customized peptides for personalized medicine”, and has developed a number of peptide products with independent intellectual property. During this forum, we actively participated in the interactive discussions related to the peptide industry, and set up a booth to showcase the corporate style.

The meeting promoted the communication and information sharing among government management departments, peptide industry experts and peer enterprises. Meanwhile, it provided a platform for biochemical enterprises to communicate and learn, which was conducive to promoting the healthy development of Chinese peptide pharmaceutical industry.